Deciphera Pharmaceuticals (DCPH) Tops Q2 EPS by 5c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($0.57), $0.05 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $38.3 million versus the consensus estimate of $36.1 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Bit Digital (BTBT) Misses Q2 EPS by 27c
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp